State of Alaska Department of Revenue Buys 14,470 Shares of Humana Inc (HUM)
State of Alaska Department of Revenue grew its stake in shares of Humana Inc (NYSE:HUM) by 102.8% during the 4th quarter, HoldingsChannel reports. The fund owned 28,552 shares of the insurance provider’s stock after buying an additional 14,470 shares during the period. State of Alaska Department of Revenue’s holdings in Humana were worth $7,080,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of the business. FMR LLC increased its holdings in shares of Humana by 29.3% in the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after purchasing an additional 1,479,210 shares during the period. Capital Research Global Investors increased its holdings in shares of Humana by 9.7% in the second quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock worth $940,182,000 after purchasing an additional 346,069 shares during the period. Renaissance Technologies LLC increased its holdings in shares of Humana by 1.5% in the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock worth $657,157,000 after purchasing an additional 39,400 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Humana by 74.1% in the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock worth $664,921,000 after purchasing an additional 1,161,661 shares during the period. Finally, Wells Fargo & Company MN increased its holdings in shares of Humana by 10.0% in the third quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock worth $402,799,000 after purchasing an additional 150,173 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.
Humana Inc (NYSE HUM) opened at $279.30 on Friday. The company has a market capitalization of $39,920.82, a price-to-earnings ratio of 21.97, a P/E/G ratio of 1.75 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. Humana Inc has a 12 month low of $186.25 and a 12 month high of $280.93.
Humana announced that its board has initiated a stock repurchase plan on Thursday, December 14th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the insurance provider to repurchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.57%. Humana’s dividend payout ratio is presently 12.59%.
In related news, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction on Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the transaction, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. In the last three months, insiders sold 10,115 shares of company stock worth $2,501,627. 0.80% of the stock is owned by insiders.
HUM has been the topic of several research analyst reports. BMO Capital Markets upped their price target on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, November 10th. Cowen reaffirmed a “buy” rating and issued a $285.00 price target on shares of Humana in a report on Wednesday, December 13th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $242.00 price target (down previously from $245.00) on shares of Humana in a report on Thursday, November 9th. Credit Suisse Group decreased their price target on shares of Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a report on Friday, November 10th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $230.00 price target on shares of Humana in a report on Tuesday, December 5th. Ten equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Humana has an average rating of “Buy” and a consensus target price of $260.10.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.